Kaczmarek, E <br/><br/>
Long-term survival in HER2-positive metastatic breast cancer treated with first-line trastuzumab: results from the french real-life curie database.  [electronic resource] 

 -  Breast cancer research and treatment  Dec 2019 
 - 505-512 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1573-7217 
<br/><br/><label>Standard No.: </label>10.1007/s10549-019-05423-5  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents, Immunological--therapeutic use<br/>Breast Neoplasms--drug therapy<br/>Databases, Factual<br/>Female<br/>Humans<br/>Kaplan-Meier Estimate<br/>Middle Aged<br/>Progression-Free Survival<br/>Receptor, ErbB-2--metabolism<br/>Trastuzumab--therapeutic use